Purpose: There is evidence that novel psychoactive substances (NPS) are commonly used by people with severe mental illness. The aim of the study was to undertake a scoping survey to explore inpatient mental health workers' perceptions of NPS use by consumers. Design/methodology: A cross-sectional online survey of mental health professionals. Participants were opportunistically recruited through social media and professional networks. Findings: A total of 98 participants (of 175 who started the survey) were included in the analysis. All reported that some patients had used NPS prior to admission. Over 90% of participants reported observing at least one adverse event relating to NPS use in the previous month. The majority of par...
Novel Psychoactive Substances (NPS) are chemical substances that have been synthesised to cause simi...
INTRODUCTION: As Novel psychoactive substances (NPS) are conceived to mimic the effects of common il...
Background: There are over 450 new psychoactive substances (NPS) circulating in Europe. In 2013, NPS...
Objective: It is unclear how healthcare professionals (HCPs) experience and view the challenges of w...
Objectives: Non-illicit alternatives to controlled drugs, known as Novel Psychoactive Substances (NP...
Substance misuse services need to meet the growing demand and needs of individuals using new psychoa...
Submitted 28 january 2020. Reviwers' comments received 11 February 2020. Accepted 26 February 2020. ...
This is an open access article distributed under the Creative Commons Attribution License which perm...
© 2017 John Wiley & Sons, Ltd. This is the peer reviewed version of the following article: Deligiann...
Objective: Comorbidities between psychiatric diseases and consumption of traditional substances of a...
INTRODUCTION: Novel psychoactive substances (NPS; a.k.a. 'legal highs' or 'smart drugs') are adverti...
Background Mental health problems are common in people with substance misuse problems. However, ther...
The use of novel psychoactive substances (NPS) or ‘legal highs’ is an emerging issue worldwide. Ther...
Introduction: Over the past 10 years, a large number of New Psychoactive Substances (NPS) have enter...
Background Mental health problems are common in people with substance misuse problems. However, ther...
Novel Psychoactive Substances (NPS) are chemical substances that have been synthesised to cause simi...
INTRODUCTION: As Novel psychoactive substances (NPS) are conceived to mimic the effects of common il...
Background: There are over 450 new psychoactive substances (NPS) circulating in Europe. In 2013, NPS...
Objective: It is unclear how healthcare professionals (HCPs) experience and view the challenges of w...
Objectives: Non-illicit alternatives to controlled drugs, known as Novel Psychoactive Substances (NP...
Substance misuse services need to meet the growing demand and needs of individuals using new psychoa...
Submitted 28 january 2020. Reviwers' comments received 11 February 2020. Accepted 26 February 2020. ...
This is an open access article distributed under the Creative Commons Attribution License which perm...
© 2017 John Wiley & Sons, Ltd. This is the peer reviewed version of the following article: Deligiann...
Objective: Comorbidities between psychiatric diseases and consumption of traditional substances of a...
INTRODUCTION: Novel psychoactive substances (NPS; a.k.a. 'legal highs' or 'smart drugs') are adverti...
Background Mental health problems are common in people with substance misuse problems. However, ther...
The use of novel psychoactive substances (NPS) or ‘legal highs’ is an emerging issue worldwide. Ther...
Introduction: Over the past 10 years, a large number of New Psychoactive Substances (NPS) have enter...
Background Mental health problems are common in people with substance misuse problems. However, ther...
Novel Psychoactive Substances (NPS) are chemical substances that have been synthesised to cause simi...
INTRODUCTION: As Novel psychoactive substances (NPS) are conceived to mimic the effects of common il...
Background: There are over 450 new psychoactive substances (NPS) circulating in Europe. In 2013, NPS...